The global bioabsorbable stents market size is expected to grow from $0.29 billion in 2021 to $0.31 billion in 2022 at a compound annual growth rate (CAGR) of 8.1%. The global bioabsorbable stent market is then expected to grow to $0.45 billion in 2026 at a CAGR of 9.5%.
What is the Global Bioabsorbable Stents Market?
The bioabsorbable stents market consists of sales of bioabsorbable stents and related services. Bioabsorbable stents, also known as Bioresorbable stents (BRS) or vascular scaffolds are coronary stents that can fully dissolve in the body. These biodegradable stents are used in percutaneous coronary intervention (PCI) procedures for providing structural support to the treated vessels and preventing acute recoil & restenosis. Bioabsorbable stents are commonly used in the treatment of heart diseases.
Get a Sample of the global bioabsorbable stents market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp
What drives the Global Bioabsorbable Stents Market?
Increasing cardiovascular diseases is a key factor driving the growth of the bioabsorbable stents market. Cardiovascular disorders are the leading cause of death across the world and 4 out of 5 cardiovascular deaths are caused by strokes and heart attacks. Moreover, one-third of such deaths occur prematurely in people under the age of 70. Bioresorbable stents are built primarily to reduce these risks of late complications, such as scaffold thrombosis or restenosis, that can happen when a conventional metal stent's rigid metal backbone remains permanently rooted in the diseased vessel. According to the American Heart Association, it is estimated that more than 23.6 million die due to cardiovascular diseases by 2030. Therefore, increasing cardiovascular diseases are expected to drive the growth of the bioabsorbable stents market.
Get the full global bioabsorbable stents industry report here
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Global Bioabsorbable Stents Market Segments
The global bioabsorbable stents market is segmented:
By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
By Absorption Rate: Slow-Absorption Stents, Fast-Absorption Stents
By Application: Coronary Artery Diseases, Peripheral Artery Diseases
By Geography: The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Bioabsorbable Stents Global Market Report 2022provides market size and growth forecasts for the global bioabsorbable stents market, global bioabsorbable stents market share, bioabsorbable stents market segments and geographies, bioabsorbable stents market competitive landscape including leading competitors’ revenues, profiles and market shares. The bioabsorbable stents market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Bioabsorbable Stents Industry Playersinclude Abbott Laboratories, Reva Medical, Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical, Tepha, Inc., S3V Vascular Technologies, ICON Interventional Systems, and Arterius Limited. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
